Crataegus tanacetifolia leaf extract prevents L-NAME-induced hypertension in rats: A morphological study

Phytotherapy Research

Volumn 20, Issue 1, 2006, Pages 66-70

  Koçyildiz, Z Çelebi ^a   Birman, H ^a   Olgac V ^a   Akgun Dar K ^a   Melikoglu G ^a   Mericli A H ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Arterial blood pressure; Arterial wall; Cardiovascular; Crataegus; L NAME; Lipid levels

Indexed keywords

AMINE; ANTIHYPERTENSIVE AGENT; AROMATIC CARBOXYLIC ACID; CARDIOTONIC AGENT; CRATAEGUS EXTRACT; FLAVONOID; HYPERIN; N(G) NITROARGININE METHYL ESTER; PROCYANIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTERY WALL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY; CRATAEGUS; CRATAEGUS TANACETIFOLIA; DRUG EFFICACY; HEART FAILURE; HYPERTENSION; MALE; MORPHOLOGY; NONHUMAN; PLANT LEAF; RAT; TREATMENT OUTCOME;

ANIMALS; BLOOD PRESSURE; CORONARY VESSELS; CRATAEGUS; ENZYME INHIBITORS; HYPERTENSION; KIDNEY; LIPIDS; MALE; MYOCARDIUM; MYOCYTES, SMOOTH MUSCLE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PLANT EXTRACTS; PLANT LEAVES; QUERCETIN; RATS;

ANIMALIA; CRATAEGUS;

EID: 31644441996     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1808     Document Type: Article

References (32)

1. Ammon HPT, Haendel M. 1981. Crataegus toxicology and pharmacology. Part II: Pharmocodynamics. Planta Med 43: 209-239.
2. Bahorun T, Trotin F, Pommery J, Vasseur J, Pinkas M. 1994. Antioxidant activites of Crataegus monogyna extracts. Planta Med 60: 323-328.
3. Balaszczuk AM, Tomat A, Bellucci S, Fellet A, Arranz C. 2002. Nitric oxide synthase blockade and body fluid volumes. Braz J Med Biol Res 35: 131-134.
4. Birman H. 2001. The effect of Crataegus tanacetifolia leaves extract on blood biochemistry. Acta Pharm Turcica XLIII: 147-150.
5. Birman H, Tamer Ş, Melikoǧlu G, Meriçli AH. 2001. Hypotensive activity of Crataegus tanacetifolia. J Fac Pharm Istanbul Univ 34: 23-26.
6. Chen ZX, Zhang ZS, Kwan KY, Zhu M, HO WK. 1998. Endothelium dependent relaxation induced by Hawthorn extract in rat mesenteric artery. Life Sci 53: 1983-1991.
7. Duarte J, Jimenez R, O'Valle F, Galisteo M, Perez-Palencia R, Vargas F, Perez-Vizcaino F, Zarzuleo A, Tamargo J. 2002. Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertension 20: 1843-1854.
8. Garjani A, Nazemiyev H, Maleki N, Valizadeh H. 2000. Effects of extracts from flowering tops of Crataegus meyeri A. Pojark. on ischaemic arrhythmias in anaesthetized rats. Phytother Res 14: 428-431.
9. Granger JP, Alexander BT. 2000. Abnormal pressure-natriuresis in hypertension: role of nitric oxide. Acta Physiol Scand 168: 161-168.
10. Gryglewski RJ, Korbut R, Robak J, Swies J. 1987. On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol 36: 317-322.
11. Hirvonen T, Pietinen P, Virtanen M et al. 2001. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 12: 62-67.
12. Jouad H, Lacaille-Dubois MA, Lyoussi B, Eddouks M. 2001. Effect of the flavonoids extracted from Spergularia purpurea Pers. on arterial blood pressure and renal function in normal and hypertensive rats. J Ethnopharmacol 76: 159-163.
13. Khedara A, Goto T, Morishima M, Kayashita J, Kato N. 1999. Elevated body fat in rats by the dietary nitric oxide synthase inhibitor, L-N omega nitroarginine. Biosci Biotechnol Biochem 63: 698-702.
14. Khedara A, Kawai Y, Kayashita J, Kato N. 1996. Feeding rats the nitric oxide synthase inhibitor, L-N (omega) nitroarginine, elevates triglyceride and cholesterol and lowers hepatic fatty acid oxidation. J Nutr 126: 2563-2567.
15. Kim SH, Kang KW, Kim KW, Kim ND. 2000. Procyanidins in Crataegus extract evoke endothelium dependent vasorelaxation in rat aorta. Life Sci 67: 121-131.
16. Lacaille-Dubois MA, Franck U, Wagner H. 2001. Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine 8: 47-50.
17. Loew D. 1999. Phytogenic drugs in heart diseases exemplified by Crataegus. Wien Med Wochenschr 149: 226-228.
18. Melis MS. 1992. Stevioside effect on renal function of normal and hypertensive rats. J Ethnopharmacol 36: 213-217.
19. Meriçli AH, Ergezen K. 1994. Flavonoids of Crataegus tanacetifolia (Lam.) Pers. (Rosaceae), an endemic species from Turkey. Sci Pharm 62: 277-281.
20. Müller A, Linke W, Klaus W. 1999. Crataegus extracts blocks potassium currents guinea pig ventricular cardiac myocytes. Planta Med 65: 335-339.
21. Perez-Vizcaino F, Ibarra M, Cogolludo AL et al. 2002. Vasodilator effect of quercetin and its metabolites, isorhamnetin and tamarixetin in rat isolated vessels. J Pharm Exp Ther 302: 66-72.
22. Pinelli A, Trivulzio S, Tomasoni L et al. 2003. Drugs modifiying nitric oxide metabolism affect plasma cholesterol levels, coagulation parameters, blood pressure values and appearance of plasma myocardial necrosis markers in rabbits: opposite effects of L-NAME and nitroglycerine. Cardiovasc Drugs Ther 17: 15-23.
23. Qiu C, Muchant D, Beierwaltes W, Racusen L, Baylis C. 1998. Evolution of chronic nitric oxide inhibition hypertension: Relationship to renal function. Hypertension 31: 21-26.
24. Schussler M, Holzl J, Fricke U. 1995. Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung Drug Res 45 (II), Nr.8.
25. Schussler M, Holz J, Rump AF, Fricke U. 1995. Functional and antiischaemic effects of monoacetyl-vitexinrhamnoside in different in vitro models. Gen Pharmacol 26: 1565-1570.
26. Taskov M. 1977. On the coronary and cardiotonic action of crataemon. Acta Physiol Pharmacol Bulg 3: 53-57.
27. Thompson EB, Aynilian GH, Gora P, Farnsworth NR. 1974. Preliminary study of potential antiarrhytmic effects of Crataegus monogyna. JI Pharm Sci 63: 1936-1937.
28. Tost H, Hably C, Lengyel M, Gogl A, Lendvai A, Bartha J. 2000. Effect of nitric oxide synthase inhibition on renal circulation and excretory function in anaesthetized rats. Exp Physiol 85: 791-800.
29. Wagner H, Grevel J. 1982. Cardiotonic amines from Crataegus oxycantha. Planta Med 45: 98-101.
30. Weiss RF. 1988. Herbal Medizin, 6th edn. AB Arcanum: Gothenburg, Sweden.
31. Zhang Z, Ho WKK, Huang Y, James AE, Lam LW, Chen ZY. 2002. Hawthorn fruit is hypolipidemic in rabbits fed a high cholesterol diet. J Nutr 132: 5-10.
32. Zats R, Baylis C. 1998. Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964.